Bibliography
- Cyranoski D. Japan aims high for growth. Nature 2013;497:548
- Economist. Healthcare in Japan – regenerative medicine. 2013
- Economist. Biotechnology – fever rising. 2014
- Cabinet Public Relations Office, Cabinet Secretariat. Japan revitalization strategy - examples of major policies 3. 2013
- Japan External Trade Organization. Attractive sectors – life sciences 1. 2013
- America’s pharmaceutical industry has recognized and sourced Japanese pharmaceutical innovations to supplement its pipeline. see Landers P. With dry pipelines, big drug makers stock up in Japan. Wall St J Nov 24, 2003 at A1 and Landers P, Singer J. Pharmaceutical makers see feast in Japan. Wall St J 29 April. 2002 at C1
- Graul A. 2013 Pharma innovation: 10 first-in-class drugs reach the marketplace. Life Sciences Connect: Thomson Reuters Blog. 2014
- Tokkyo Ho [Patent Law]. Law No. 121 of 1959, as amended
- Astellas & Fujisawa v. Commissioner Japan patent office. Heisei 17 (gyo-ke) 10312 dated 30 Aug., 2005 (Intellectual Property H. Ct.)
- Stanford University v. Commissioner Japan Patent Office Heisei 10 (gyo-ke) 95 dated 22 Feb 2000 (Tokyo H. Ct.)
- Japan Patent Office. Part VII examination guidelines for inventions in specific fields - medicinal inventions. In: Examination guidelines for patent and utility model in Japan. The Bureau of National Affairs, Inc., Bloomberg BNA, 2013. p. 3-4
- The Procter & Gamble Company v. Commissioner Japan Patent Office, Heisei 21 (gyo-ke) 10238 dated 15 Jul 2010 (Intellectual Property H. Ct.)
- Boehringer Ingelheim v. Commissioner Japan Patent Office, Heisei 21(Gyo-ke)10033 dated 28 Jan 2010 (Intellectual Property H. Ct.)
- Allied Chemical Corp. v. Commissioner Japan Patent Office, Showa 60 (gyo-ke) 51 dated 8 Sep 1987 (Tokyo High Ct.)
- Glaxo Group Ltd. v. Commissioner Japan Patent Office, Heisei 15 (gyo-ke) 104, dated 26 Dec 2003 (Tokyo H. Ct.)
- Teva Gogyszergyar v. Kyowa Hakko Kirin Co., Ltd, Heisei 22 (ne) 10043 dated 27 Jan 2012 (Intell. Prop. High Ct.)
- Tessensohn JA; Shusaku Yamamoto. New invalidation appeal system. Euro Intell Prop Rev 2003;25(10):N-154
- Tessensohn JA. Proposed changes to Japan’s intellectual property legal regime in 2014. World Intell Prop Rev 2014;28(5):13-14
- THK Co. v. Tsubakimoto Seiko Co. 1630 Hanrei Jiho 32 (Sup. Ct. Feb. 24, 1998)
- Ono Pharmaceutical v. Kyoto Pharmaceutical 1675 Hanrei Jiho 37 (Sup. Ct. Apr. 16, 1999)
- Monsanto Co. v Stauffer Japan KK 1246 Hanrei Jiho 128 (Tokyo Dist Ct, July 10 1987)
- X. v. Mitsubishi Chemical Industrial K.K., Heisei 21 (gyo-ke) 17204, dated Feb. 17, 2012 (Intell. Prop. H. Ct.)
- Deloitte. 2014 Global life sciences outlook Resilience and reinvention in a changing marketplace. 2014